HTRA-1 mAbs (Navigen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHTRA-1 mAbs (Navigen)

Drug Alias NameHTRA-1 polyclonal antibodies (Navigen)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies

Mechanisms of ActionSerine protease HTRA1 inhibitors

TargetsSerine protease HTRA1

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNavigen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNavigen

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A